Welcome to Investor.theravance.com - Theravance Biopharma

investor.theravance.com

Description: Investor Theravance. Pipeline Programs. Theravance Biopharma is a biopharmaceutical company with one approved product that was discovered and developed...

Google PR 4

Trustworthiness Unknown
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Unknown

Theravance Biopharma :: Investor Relations

Investor.theravance.com: get to the top rated Investor Theravance pages and content popular with USA-based Investor.theravance.com users or check the following digest to find out more. Investor.theravance.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Investor.theravance.com team has yet to grow their social media activity, as the major social networks contain little or no materials related to this domain. Investor.theravance.com is hosted with Akamai Technologies, Inc. in United States. Investor Theravance traffic is not yet estimated by Alexa.

Visit investor.theravance.com

Domain info

Location:	United States
Registrant:	Registration Private (Domains By Proxy, LLC)
Hosted by:	Akamai Technologies, Inc.
Registrar:	GoDaddy.com, LLC
Subnetworks:	23.48.104.102

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: -
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Investor.theravance.com popular pages to visit

Theravance Biopharma, Inc.: Management Team Pipeline Programs. Theravance Biopharma is a biopharmaceutical company with one approved product that was discovered and developed internally, a pipeline of internally discovered product candidates an...

Theravance Biopharma :: Investor Relations Theravance Biopharma, Inc.’s focus is to deliver Medicines that Make a Difference ® in people’s lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to...